| ankylosing spondylitis |
001 |
| antioxidant capacity |
001 |
| dietary phytochemical index |
001 |
| oxidant capacity |
001 |
| adult-onset still’s disease |
011 |
| anakinra |
011 |
| tocilizumab |
011 |
| treatment |
011 |
| carpal tunnel syndrome |
019 |
| diagnostic ultrasonography |
019 |
| electrophysiology |
019 |
| low-level laser therapy |
019 |
| antiphospholipid antibodies |
031 |
| antiphospholipid syndrome |
031 |
| pakistan |
031 |
| pregnancy outcome |
031 |
| atherosclerosis |
040 |
| cardiovascular disease |
040 |
| carotid intima-media thickness |
040 |
| lipoprotein associated phospholipase a2 |
040 |
| primary sjögren syndrome |
040 |
| histopathology |
049 |
| minor salivary gland |
049 |
| sjögren’s syndrome |
049 |
| adverse pregnancy outcomes |
059 |
| preeclampsia |
059 |
| systemic lupus erythematosus |
059 |
| fibromyalgia syndrome |
067 |
| hemodialysis |
067 |
| peritoneal dialysis |
067 |
| renal transplantation |
067 |
| disease activity score |
077 |
| rheumatoid arthritis |
077, 085, 094 |
| shoulder joint |
077 |
| ultrasound |
077 |
| diagnosis delay |
085 |
| disease management |
085 |
| therapeutics |
085 |
| dental follicle mesenchymal stem cells |
094 |
| synovial fluid |
094 |
| acute phase reactants |
110 |
| axial spondyloarthropathy |
110 |
| disease activity |
110 |
| progranulin |
110 |
| hip |
119 |
| knee |
119 |
| mini-osteoarthritis knee and hip quality of life |
119 |
| osteoarthritis |
119 |
| reliability |
119 |
| turkish |
119 |
| validity |
119 |
| anti-neutrophil cytoplasmic antibody-associated vasculitis |
129 |
| cardiovascular risk |
129 |
| speckle-tracking echocardiography |
129 |
| strain |
129 |
